Report cover image

France Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Publisher GlobalData
Published Jun 23, 2025
Length 153 Pages
SKU # GBDT20178461

Description

France Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Summary

GlobalData’s “France Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the France Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The France Oncology Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Oncology Market.
  • Global corporate-level profiles of key companies operating within the France Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

France Oncology is segmented as follows -
  • Colorectal Cancer Screening Tests
  • EGFR Tests
  • KRAS Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • BRAF Tests
  • BCR-ABL Tests
  • PD-L1 Tests
Reasons to Buy

The France Oncology Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

153 Pages
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Oncology Market, France
3.1 Oncology Market, France, Revenue ($m), 2018-2033
3.1.1 ALK Tests Market, France, Revenue ($m), by Segment, 2018-2033
3.1.2 BCR-ABL Tests Market, France, Revenue ($m), by Segment, 2018-2033
3.1.3 BRAF Tests Market, France, Revenue ($m), by Segment, 2018-2033
3.1.4 BRCA Tests Market, France, Revenue ($m), by Segment, 2018-2033
3.1.5 Colorectal Cancer Screening Tests Market, France, Revenue ($m), by Segment, 2018-2033
3.1.6 EGFR Tests Market, France, Revenue ($m), by Segment, 2018-2033
3.1.7 HER2 Tests Market, France, Revenue ($m), by Segment, 2018-2033
3.1.8 KRAS Tests Market, France, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, France, Volume (Units), 2018-2033
3.2.1 ALK Tests Market, France, Volume (Units), by Segment, 2018-2033
3.2.2 BCR-ABL Tests Market, France, Volume (Units), by Segment, 2018-2033
3.2.3 BRAF Tests Market, France, Volume (Units), by Segment, 2018-2033
3.2.4 BRCA Tests Market, France, Volume (Units), by Segment, 2018-2033
3.2.5 Colorectal Cancer Screening Tests Market, France, Volume (Units), by Segment, 2018-2033
3.2.6 EGFR Tests Market, France, Volume (Units), by Segment, 2018-2033
3.2.7 HER2 Tests Market, France, Volume (Units), by Segment, 2018-2033
3.2.8 KRAS Tests Market, France, Volume (Units), by Segment, 2018-2033
3.3 Oncology Market, France, Average Price ($) , 2018-2033
3.4 Oncology Market, France, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in France, Oncology Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Agilent Technologies Inc
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Qiagen NV
4.4.1 Company Overview
4.5 Danaher Corp
4.5.1 Company Overview
4.6 Eiken Chemical Co Ltd
4.6.1 Company Overview
4.7 Resonac Corporation
4.7.1 Company Overview
4.8 Alfresa Pharma Corp
4.8.1 Company Overview
4.9 Hemosure Inc
4.9.1 Company Overview
4.10 SENTINEL CH SpA
4.9.1 Company Overview
5 Oncology Market Pipeline Products
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 Ikonisys Raises USD0.16 Million in Private Placement of Shares
6.1.2 Phaxiam Therapeutics Raises USD8.39 Million in Private Placement of Shares
6.2 Partnerships
6.2.1 A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
6.3 Private Equity
6.3.1 Consortium of Investor to Acquire Eurobio Scientific
6.4 Venture Financing
6.4.1 HEPTA Medical Raises USD6.29 Million in Series A Financing
6.4.2 Spotlight Medical Raises USD6.72 Million in Seed Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 11, 2025: UK-backed AI Companies to Transform British Cancer Care and Spark New Drug Breakthroughs
7.1.2 Oct 03, 2024: Successful 2024 ISO 13485 Certification Maintenance Strengthening Ikonisys’ Strong Market Position and Growth Potential
7.2 Government and Public Interest
7.2.1 Apr 14, 2025: Tackling Vulnerabilities in the Supply Chain of Radiopharmaceuticals in the EU
7.3 Other Significant Developments
7.3.1 Jan 06, 2025: PhenoVista Biosciences Partners with NETRI to Expand Organ-on-Chip Service Offerings for Drug Development
7.3.2 Nov 12, 2024: Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax’s CE IVD-Certified Technology in Oncological Diagnostics and Organ Transplant Safety
7.3.3 Oct 31, 2024: CURE51 Chooses 10X Genomics Visium HD for New Drug Discovery Initiative
7.3.4 Sep 17, 2024: Precision Microbiome Profiling Demonstrates It Diagnostic Potential in Groundbreaking Work Conducted at Gustave Roussy Cancer Institute
7.4 Product News
7.4.1 Apr 08, 2025: Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM
7.4.2 Jan 20, 2025: Biomarkers in Immuno-Oncology: Identifying and Implementing Biomarker Testing From Exploratory Research to Clinical Trials
7.4.3 Dec 03, 2024: The Ikonisys Group Unveils its New Vision and Strategy Under the Brand “ALIKO SCIENTIFIC”
7.4.4 Nov 21, 2024: Prestigious Cancer Center Institut Curie Introduces Ibex Medical Analytics’ AI Tools for Cancer Diagnostics
7.4.5 Aug 26, 2024: Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors
7.5 Strategy And Business Planning
7.5.1 Feb 26, 2025: OncoHost Announces Collaboration With Gustave Roussy
7.5.2 Jan 06, 2025: PhenoVista Biosciences Partners with NETRI to Expand Organ-on-Chip Service Offerings for Drug Development
7.5.3 Nov 25, 2024: French Hospital Joins Regional Pathology Solution From Sectra to Enhance Collaboration and Speed Up Cancer Diagnostics
7.5.4 Sep 24, 2024: Curium Opens Additional and New Facility in Petten, Netherlands
7.5.5 Jun 27, 2024: Spotlight Medical Emerges from Stealth to Tackle the Critical Issue of Inadequate Cancer Treatments
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
sssssss8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Oncology Market, France, Revenue ($m), USD Constant, 2018-2033
Table 2: ALK Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 3: BCR-ABL Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 4: BRAF Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 5: BRCA Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 6: Colorectal Cancer Screening Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 7: EGFR Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 8: HER2 Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 9: KRAS Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Table 10: Oncology Market, France, Volume (Units), 2018-2033
Table 11: ALK Tests Market, France, Volume (Units), 2018-2033
Table 12: BCR-ABL Tests Market, France, Volume (Units), 2018-2033
Table 13: BRAF Tests Market, France, Volume (Units), 2018-2033
Table 14: BRCA Tests Market, France, Volume (Units), 2018-2033
Table 15: Colorectal Cancer Screening Tests Market, France, Volume (Units), 2018-2033
Table 16: EGFR Tests Market, France, Volume (Units), 2018-2033
Table 17: HER2 Tests Market, France, Volume (Units), 2018-2033
Table 18: KRAS Tests Market, France, Volume (Units), 2018-2033
Table 19: Oncology Market, France, Average Price ($), 2018-2033
Table 20: Oncology Market, France, Company Share by Revenue ($m), 2024
Table 21: Oncology Market Pipeline Products
Table 22: Ikonisys Raises USD0.16 Million in Private Placement of Shares
Table 23: Phaxiam Therapeutics Raises USD8.39 Million in Private Placement of Shares
Table 24: A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
Table 25: Consortium of Investor to Acquire Eurobio Scientific
Table 26: HEPTA Medical Raises USD6.29 Million in Series A Financing
Table 27: Spotlight Medical Raises USD6.72 Million in Seed Financing
Table 28: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Oncology Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 2: ALK Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 3: BCR-ABL Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 4: BRAF Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 5: BRCA Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 6: Colorectal Cancer Screening Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 7: EGFR Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 8: HER2 Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 9: KRAS Tests Market, France, Revenue ($m), USD Constant, 2018-2033
Figure 10: Oncology Market, France, Volume (Units), 2018-2033
Figure 11: ALK Tests Market, France, Volume (Units), 2018-2033
Figure 12: BCR-ABL Tests Market, France, Volume (Units), 2018-2033
Figure 13: BRAF Tests Market, France, Volume (Units), 2018-2033
Figure 14: BRCA Tests Market, France, Volume (Units), 2018-2033
Figure 15: Colorectal Cancer Screening Tests Market, France, Volume (Units), 2018-2033
Figure 16: EGFR Tests Market, France, Volume (Units), 2018-2033
Figure 17: HER2 Tests Market, France, Volume (Units), 2018-2033
Figure 18: KRAS Tests Market, France, Volume (Units), 2018-2033
Figure 19: Oncology Market, France, Company Share (%), 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us